Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $76.37 ($127,304)
  4. 4 Planned sale CHIEF OPERATING OFFICER sold 3,000 shares at an average $76.34 ($229,013)
  5. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,616 shares at an average $76.33 ($199,690)
  6. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $75.64 ($1,134,579)
  7. 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $71.92 ($575,375)
  8. 4 Shares withheld for taxes SVP, GEN COUNSEL & CORP SEC gave up 335 shares (to pay taxes)
  9. 4 Grant or award Director acquired 1,550 shares (grant or award)
  10. 4 Grant or award Director acquired 1,550 shares (grant or award)
  11. 4 Grant or award Director acquired 1,550 shares (grant or award)
  12. 4 Grant or award Director acquired 1,550 shares (grant or award)
  13. 4 Grant or award Director acquired 1,550 shares (grant or award)
  14. 4 Grant or award Director acquired 1,550 shares (grant or award)
  15. 4 Grant or award Director acquired 1,550 shares (grant or award)
  16. 4 Planned sale Director sold 18,200 shares at $73.00 ($1,328,600)
  17. 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $72.06 ($120,127)
  18. 4 Planned sale CHIEF OPERATING OFFICER sold 3,000 shares at an average $71.99 ($215,961)
  19. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,616 shares at an average $72.06 ($188,512)
  20. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $69.43 ($1,041,408)

Page 8 of 22 · 421 filings